Key Market Indicators
Sales of beta-blocking medication in Spain are set to reach €110 million (roughly $124.35 million) by 2026, according to a report. The report shows that in 2021, Spanish beta-blocking medicine sales were €112 million (roughly $123.2 million). This is a 0.6% year-on-year growth from the previous year. Since 2009, the Spanish market has seen a 5.3% year-on-year growth. In 2021, Australia overtook Spain as the top market for beta-blocking medication sales, with €112 million (roughly $123.2 million). Italy, Canada and Australia respectively were numbers 2, 3 and 4 in this ranking.
